Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides

Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides

Sialylated glycolipids, gangliosides play an essential role in the central nervous system regulating recognition and signaling in neurons. Metabolic blocks in processing and catabolism of gangliosides result in development of severe neurological disorders, gangliosidoses manifesting with neurodegene...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Pan, X, De Britto Pará De Aragão, C, Velasco-Martin, J, Priestman, D, Wu, H, Takahashi, K, Yamaguchi, K, Sturiale, L, Garozzo, D, Platt, F, Lamarche-Vane, N, Morales, C, Miyagi, T, Pshezhetsky, A
Format:	Journal article
Veröffentlicht:	Federation of American Society of Experimental Biology (FASEB) 2017

Ähnliche Einträge

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
von: Pshezhetsky, A, et al.
Veröffentlicht: (2017)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
von: Pshezhetsky, A, et al.
Veröffentlicht: (2017)

Altered expression of ganglioside metabolizing enzymes results in GM3 ganglioside accumulation in cerebellar cells of a mouse model of juvenile neuronal ceroid lipofuscinosis
von: Somogyi, A, et al.
Veröffentlicht: (2018)

An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions
von: Clark, A, et al.
Veröffentlicht: (2021)

Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption
von: Ikhui Kho, et al.
Veröffentlicht: (2023-10-01)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
von: Huebecker, M, et al.
Veröffentlicht: (2019)

Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
von: Harlalka, G, et al.
Veröffentlicht: (2013)

Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms
von: Viana, GM, et al.
Veröffentlicht: (2020)

Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury.
von: Townson, K, et al.
Veröffentlicht: (2008)

Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
von: Viana, GM, et al.
Veröffentlicht: (2020)

Ganglioside antibodies and neuropathies.
von: Rinaldi, S, et al.
Veröffentlicht: (2008)

Editorial: Pharmacology of gangliosides
von: Hongda Zhuang, et al.
Veröffentlicht: (2024-07-01)

TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells
von: Paget, C, et al.
Veröffentlicht: (2019)

GM1 ganglioside-independent intoxication by Cholera toxin
von: Cervin, J, et al.
Veröffentlicht: (2018)

Influenza neuraminidase mutations and resistance to neuraminidase inhibitors
von: Jiapeng Xu, et al.
Veröffentlicht: (2024-12-01)

N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
von: Kasperzyk, J, et al.
Veröffentlicht: (2004)

Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
von: Kasperzyk, J, et al.
Veröffentlicht: (2002)

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
von: Ranes, M, et al.
Veröffentlicht: (2001)

Neuraminidase B controls neuraminidase A-dependent mucus production and evasion.
von: Alexandria J Hammond, et al.
Veröffentlicht: (2021-04-01)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
von: Baek, R, et al.
Veröffentlicht: (2008)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
von: Baek, R, et al.
Veröffentlicht: (2004)

Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice
von: Baek, R, et al.
Veröffentlicht: (2005)

244 Targeting gangliosides in pediatric cancer
von: Min Huang, et al.
Veröffentlicht: (2023-11-01)

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
von: Kasperzyk, J, et al.
Veröffentlicht: (2004)

Neuraminidase inhibitors for influenza complications.
von: Del Mar, C, et al.
Veröffentlicht: (2014)

Dietary Ganglioside Reduces Proinflammatory Signaling in the Intestine
von: John Janez Miklavcic, et al.
Veröffentlicht: (2012-01-01)

9-O Acetylated Gangliosides in Health and Disease
von: Luis Vicente Herrera-Marcos, et al.
Veröffentlicht: (2023-05-01)

"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
von: Kasperzyk, J, et al.
Veröffentlicht: (2005)

Are anti-ganglioside antibodies associated with proventricular dilatation disease in birds?
von: Jeann Leal de Araujo, et al.
Veröffentlicht: (2017-04-01)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
von: Jefferson, T, et al.
Veröffentlicht: (2014)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
von: Jefferson, T, et al.
Veröffentlicht: (2014)

Pharmacokinetic Properties of Anti-Influenza Neuraminidase Inhibitors.
von: Chairat, K, et al.
Veröffentlicht: (2012)

Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
von: Chairat, K, et al.
Veröffentlicht: (2013)

Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes
von: Irma Magaly Rivas Serna, et al.
Veröffentlicht: (2022-12-01)

Gangliosides and Their Role in Multilineage Differentiation of Mesenchymal Stem Cells
von: Francesca Santilli, et al.
Veröffentlicht: (2022-12-01)

The Key Role of GM1 Ganglioside in Parkinson’s Disease
von: Suman Chowdhury, et al.
Veröffentlicht: (2022-01-01)

Studying catabolism of protein ADP-Ribosylation
von: Palazzo, L, et al.
Veröffentlicht: (2017)

New GM1 Ganglioside Derivatives for Selective Single and Double Labelling of the Natural Glycosphingolipid Skeleton
von: Polyakova, S, et al.
Veröffentlicht: (2009)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
von: Jay S Schneider
Veröffentlicht: (2018-01-01)

Neuraminidase inhibitors for preventing and treating influenza in children
von: Wang, K, et al.
Veröffentlicht: (2012)